Criticism of the paper first surfaced in 1994, and its author was accused of scientific misconduct.

The authors have requested a retraction of a paper that found people with the CCR5 Δ32 variant are more likely to die sooner.

A study estimates that 0.15 percent of genetics articles are retracted, most commonly for duplication and plagiarism.

A panel finds David Latchman’s “recklessness in the conduct” of the lab and his involvement as an author on problematic papers facilitated the misconduct.

The University of Cambridge and the University of Bristol conducted investigations of the research.

The publication of the SCIPIO trial is among many by Piero Anversa’s lab that Harvard Medical School flagged for fraudulent data.

The manuscript had amassed more than 50 comments about problematic figures and data on PubPeer.

From a self-sampling scientist to the downfall of a leading stem cell scientist, here’s our naughty list.

It’s the latest fallout from an investigation by Harvard and Brigham and Women’s into work overseen by Piero Anversa.